Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Rodman & Renshaw Clones a Bear

Rodman & Renshaw (Nasdaq: RODM  ) was optimistic about its public offering, expecting to issue 12 million shares at a price range of $5 to $7. But reality intervened, and the company ultimately sold only 8 million shares at $5 a pop on Tuesday. Worse yet, the stock quickly dropped to $4.20 as investors got jittery.

R&R helps biotech companies raise capital through private placements and other sophisticated transactions. It's a big market, with 1,100 private and 330 publicly traded companies in the space. And with the average drug requiring $1.2 billion to reach the market, biotechs often feed at Wall Street's trough.

For the most part, R&R has done quite well, capitalizing on the market opportunity. For the first six months of 2007, revenue spiked 75% to $47.2 million. The company even posted a profit of $10 million. So why is Wall Street lukewarm on R&R's public offering?

First of all, R&R gets an average 75% of its revenue from life sciences, which can be a volatile sector. If a few deals slip away, the growth rate could dampen considerably.

At the same time, R&R must compete with rivals such as Bank of America Securities (NYSE: BAC  ) , Cowen & Company (Nasdaq: COWN  ) , Jeffries & Company (NYSE: JEF  ) , Lazard (NYSE: LAZ  ) , and Thomas Weisel Partners (Nasdaq: TWPG  ) .

No doubt, R&R realizes it needs to diversify its business, which should be easier with the boost from the public offering. However, it's not an easy transition to make, and is yet another thing for Wall Street to worry about.

For more Foolishness:

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 538672, ~/Articles/ArticleHandler.aspx, 10/25/2016 5:11:00 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:00 PM
BAC $16.77 Up +0.10 +0.60%
Bank of America CAPS Rating: ****
JEF.DL $0.00 Down +0.00 +0.00%
Jefferies Group CAPS Rating: **
LAZ $35.87 Down -0.16 -0.44%
LAZARD CAPS Rating: ***